Early F-18-FDHT PET/CT as a predictor of treatment response in mCRPC treated with enzalutamide.

Hilde Hoving, Selma Palthe, Marleen Vallinga, Rutger Dost, Jourik A. Gietema, Inez Antunes, Erik F. J. De Vries, Andor Glaudemans, Igle Jan de Jong

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)232-232
Number of pages1
JournalJournal of Clinical Oncology
Issue number7_Suppl
Publication statusPublished - 1-Mar-2019
EventASCO-SITC Clinical Immuno-Oncology Symposium - San Francisco, Canada
Duration: 28-Feb-20192-Mar-2019

Cite this